Literature DB >> 3371370

18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.

H Joensuu1, A Ahonen, P J Klemi.   

Abstract

Fourteen human thyroid tumors were studied with 18F-fluorodeoxyglucose (FDG) imaging. The proliferative activity and DNA ploidy of the tumors was assessed by DNA flow cytometry. FDG accumulated in a Hürthle cell carcinoma, an anaplastic carcinoma and a thyroid lymphoma, but only slightly or not at all in the three papillary carcinomas studied. Three of the eight benign tumors also accumulated FDG, but two of these were selected for imaging because of a large number of proliferating cells in DNA flow cytometry. Two carcinomas with increased nuclear DNA content retained FDG, but a histologically benign follicular adenoma with DNA aneuploidy did not. We conclude that in addition to malignant thyroid tumors, histologically benign tumors may also accumulate FDG, and therefore the value of FDG scanning in the preoperative diagnosis of thyroid malignancy is limited.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371370     DOI: 10.1007/bf00256624

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  22 in total

1.  Imaging of hepatoma with 18F-fluorodeoxyglucose.

Authors:  R Paul; A Ahonen; D Roeda; E Nordman
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

Review 2.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

3.  Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat.

Authors:  R Paul; R Johansson; P L Kellokumpu-Lehtinen; K O Söderström; L Kangas
Journal:  Res Exp Med (Berl)       Date:  1985

4.  DNA aneuploidy in follicular adenomas of the thyroid gland.

Authors:  H Joensuu; P Klemi; E Eerola
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

5.  Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.

Authors:  Y Yonekura; R S Benua; A B Brill; P Som; S D Yeh; N E Kemeny; J S Fowler; R R MacGregor; R Stamm; D R Christman; A P Wolf
Journal:  J Nucl Med       Date:  1982-12       Impact factor: 10.057

6.  Flow cytometric detection of aneuploidy in colorectal adenomas.

Authors:  H F van den Ingh; G Griffioen; C J Cornelisse
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

7.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

8.  Prognosis in thyroid carcinoma.

Authors:  K O Franssila
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

9.  The use of deoxyfluoro-D-glucopyranoses and related compounds in a study of yeast hexokinase specificity.

Authors:  E M Bessell; A B Foster; J H Westwood
Journal:  Biochem J       Date:  1972-06       Impact factor: 3.857

10.  Radiotherapeutic management of primary thyroid lymphoma.

Authors:  T J Blair; R G Evans; S J Buskirk; P M Banks; J D Earle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-02       Impact factor: 7.038

View more
  8 in total

Review 1.  The role of nuclear medicine in differentiated thyroid cancer.

Authors:  Susanne Kohlfürst
Journal:  Wien Med Wochenschr       Date:  2012-07-20

Review 2.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

3.  Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.

Authors:  P Melon; A Luxen; E Hamoir; M Meurisse
Journal:  Eur J Nucl Med       Date:  1995-06

4.  The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hürthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans.

Authors:  T C Yen; H D Lin; C H Lee; S L Chang; S H Yeh
Journal:  Eur J Nucl Med       Date:  1994-09

5.  Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports.

Authors:  T S Huang; P U Chieng; C C Chang; R F Yen
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

6.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.

Authors:  F Grünwald; A Schomburg; H Bender; E Klemm; C Menzel; T Bultmann; H Palmedo; J Ruhlmann; B Kozak; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-03

7.  Relationship between thallium-201 uptake and tumour proliferative ability in thyroid nodules.

Authors:  N Kume; K Suga; K Nishigauchi; M Kawamura; N Matsunaga
Journal:  Eur J Nucl Med       Date:  1996-04

8.  Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules.

Authors:  Gulgun Buyukdereli; Yasemin Aktar; Ertan Kara; Aysun Uguz; Husnu Sonmez
Journal:  Iran J Radiol       Date:  2016-01-10       Impact factor: 0.212

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.